Blemish Control Blotting Paper
FDA Label NDC 76449-050

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Nyx Los Angeles Inc. for the product Blemish Control Blotting Paper (NDC 76449-050). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, package label.principal display panel, otc - purpose, otc - keep out of reach of children, warnings, dosage & administration, indications & usage, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

ACTIVE INGREDIENTS: Salicylic Acid 0.5%

Inactive Ingredient

INGREDIENTS: Kaolin, Titanium Dioxide, Talc

Package Label.Principal Display Panel

Image Of Package Label (Bprbc)

Image Of Package Label (Bprbc)

Otc - Purpose

Blemish Control

Otc - Keep Out Of Reach Of Children

Keep Out Of Reach Of Children

Warnings

For External Use Only

Keep Out Of Eyes

Dosage & Administration


Indications & Usage

Take a piece of NYX Blotting Paper and dab over oily areas


* Please review the disclaimer below.